Clinical trials
Completed Breast Carcinoma In Situ trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 9 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 5 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 7 |
| Ohio State University Comprehensive Cancer Center | 7 |
| National Cancer Institute (NCI) | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| Case Comprehensive Cancer Center | 3 |
| Jonsson Comprehensive Cancer Center | 3 |
| SWOG Cancer Research Network | 3 |
| Wake Forest University Health Sciences | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Carcinoma In Situ | 91 |
| Breast Neoplasms | 78 |
| Carcinoma, Intraductal, Noninfiltrating | 54 |
| Carcinoma, Lobular | 9 |
| Carcinoma, Ductal, Breast | 8 |
| Hot Flashes | 8 |
| Breast Neoplasms, Male | 6 |
| Fatigue | 3 |
| Pain | 3 |
| Anxiety Disorders | 2 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.